Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 213.75M P/E - EPS this Y 50.20% Ern Qtrly Grth -
Income -86.88M Forward P/E -2.52 EPS next Y - 50D Avg Chg -27.00%
Sales 14.92M PEG - EPS past 5Y - 200D Avg Chg -37.00%
Dividend N/A Price/Book 2.48 EPS next 5Y - 52W High Chg -66.00%
Recommedations 1.50 Quick Ratio 4.88 Shares Outstanding 41.54M 52W Low Chg 93.00%
Insider Own 28.68% ROA -68.59% Shares Float 22.51M Beta -
Inst Own 40.81% ROE - Shares Shorted/Prior 1.65M/1.55M Price 5.31
Gross Margin - Profit Margin - Avg. Volume 348,912 Target Price 9.00
Oper. Margin -602.71% Earnings Date May 9 Volume 130,613 Change -5.68%
About Carisma Therapeutics, Inc.

Carisma Therapeutics, Inc., a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. The company's ex vivo CAR-M cell therapies include CT-0508, a CAR-macrophage, which is in Phase 1 clinical trial to treat solid tumors; CT-0525, a CAR-monocyte that is in Phase 1 clinical trial to treat solid tumors; and CT-1119, a mesothelin-targeted CAR-Monocyte that is in pre-clinical stage to treat patients with advanced mesothelin-positive solid tumors, including lung cancer, mesothelioma, pancreatic cancer, ovarian cancer, and others. It is also developing in vivo CAR-M cell therapies in collaboration with Moderna Therapeutics to address multiple cancer targets; and multiple assets for the potential treatment of diseases beyond oncology, including fibrosis and other immunologic and inflammatory diseases. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

Carisma Therapeutics, Inc. News
04/24/24 Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
04/22/24 Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
04/04/24 Here's Why CARISMA THERAP (CARM) Is a Great 'Buy the Bottom' Stock Now
04/03/24 Carisma Therapeutics to Present at Upcoming Conferences
07:35 AM Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
06:00 AM Carisma Therapeutics Announces Changes to its Board of Directors
03/21/24 Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
02/28/24 Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference
02/27/24 Individual investors account for 30% of Carisma Therapeutics, Inc.'s (NASDAQ:CARM) ownership, while institutions account for 23%
12/21/23 Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/14/23 First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration
12/09/23 Here's Why We're A Bit Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation
11/28/23 Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte
11/22/23 Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference
11/11/23 Benign Growth For Carisma Therapeutics, Inc. (NASDAQ:CARM) Underpins Stock's 42% Plummet
11/09/23 Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
10/31/23 Carisma Presents Pre-Clinical Proof of Concept for in vivo CAR-M using mRNA platform in collaboration with Moderna at SITC
10/25/23 Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna at SITC 2023
10/12/23 3 Top Under-$5 Stocks for Strong Gains and Positive Outlook
09/05/23 Carisma Therapeutics to Present at Upcoming Investor Conferences
CARM Chatroom

User Image TeslamyLove Posted - 04/30/24

$CARM all I am saying to the CVR holders is that we are definitely in the time frame of a RESURGENCE in Vicinium. Will there be one? Looks like most here are thinking VICINIUM by itself. I'm thinking the Resurgence with Vicinium will be in a combo drug- we still have our name in the hat for just under 3 more years. Good luck everybody

User Image TeslamyLove Posted - 04/30/24

$CARM SENS CVR holders Here is a table from 2019 of 48 products listed as "approved". 48 products were approved that year The avg time of approval is 177 days among those 48 see the table in this link https://www.federalregister.gov/documents/2021/01/15/2021-00786/fda-drug-review-timeline-transparency-statement-of-policy#:~:text=355(j)(5)(,review%20of%20NDAs%20and%20ANDAs.

User Image TeslamyLove Posted - 04/30/24

$CARM SESN CVR holders -When were the combo trial results submitted? Courtesy of Mikes post's date it was Nov 1, 2023 +/- due to the limited info we have and I can translate. See Mike827's post dated 1 Nov 2023. From that date til today it has been 182 calendar days.

User Image TeslamyLove Posted - 04/30/24

$CARM SESN CVR holders What the regulatory path for combo drugs? -Combo drugs submit a NDA or an ANDA -FDA will approve/disapprove an ANDA application within 180 days of initial receipt of the application https://www.federalregister.gov/documents/2021/01/15/2021-00786/fda-drug-review-timeline-transparency-statement-of-policy#:~:text=355(j)(5)(,review%20of%20NDAs%20and%20ANDAs.

User Image TeslamyLove Posted - 04/30/24

$CARM SESN CVR holders: Considering the limited amount of info we have about the Astra/Zeneca combo trial with Vicinium Why isn't this combo drug listed in AZN's pipeline? The regulatory pathway is determined my the Primary Mode of Action (PMOC). In other words, which drug in the combo trial is providing the most therapeutic action or effect. That is the party responsible for taking the lead role in the regulatory process of a combo drug - Clearly between Durvalamab and Vicinium, Vicinium is THE PMOC. Since Vicinium is in the house of CARM, they have no obligation to provide any updates. So is why we haven't heard anything? https://www.google.com/search?client=safari&rls=en&q=what+is+the+regulatory+path+for+combo+drugs&ie=UTF-8&oe=UTF-8

User Image steven1x Posted - 04/29/24

$CARM for CVR holders …Vici competition https://www.globenewswire.com/en/news-release/2024/04/24/2868754/0/en/CG-Oncology-to-Unveil-Encouraging-Results-on-Cretostimogene-in-Combination-with-Pembrolizumab-at-ASCO-2024.http

User Image Guiping Posted - 04/29/24

$CARM don’t forget my CVR.

User Image SoccerPeter Posted - 04/29/24

$CARM Chardan 8th Annual Genetic Medicines & Cell Therapy Manufacturing Summit Steven Kelly, President and Chief Executive Officer, will give a corporate presentation. Monday, April 29 at 2:00 PM ET Virtual

User Image PhysicsbasedTrader Posted - 04/27/24

$CARM here is template email for you: “Hello, I am holding XX amount of SESEN BIO CVRs. I am very disappointed not receiving any status update about it. I found your behavior as pretty unethical here. If you want to grow out as small bio company, you first need to learn to act ethical to your investors. Please provide a status update for all CVRs ASAP.”

User Image PhysicsbasedTrader Posted - 04/27/24

$CARM I am holding 454,000 CVRs. I am getting no reply to my emails from Carisma IR. Please send them at least one email per month. I can’t figure any other way to have them spit out a status update.

User Image sorencyrus Posted - 04/27/24

$CARM just contacted Carisma Therapeutics asking for updates: Hi, I had 183000 SESN shares that turned into "817CVR038SESEN BIO INC COMMON STOCK CONTRA 817763105" and I would like to see an update on Vicineum and path forward. I also own 117000 shares of your company and I need to see where we stand in terms of treatments and development.

User Image Mike827 Posted - 04/26/24

$CARM Cramer says Merck should buy ibrx? Merck did everything possible to keep Vicineum from being approved all the while Vicineum sits protected in Carisma house🤔

User Image Mike827 Posted - 04/26/24

$CARM Is Vicineum ready for a resurgence?

User Image sorencyrus Posted - 04/26/24

$CARM 117000 shares and long ...

User Image PhysicsbasedTrader Posted - 04/26/24

$CARM I just sent another message to IR asking for update of Sesen bio CVRs. Please don’t be lazy and send your message as well. It takes 20 seconds.

User Image SoccerPeter Posted - 04/25/24

$CARM Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting https://ir.carismatx.com/news-releases/news-release-details/carisma-therapeutics-announces-upcoming-presentation-american

User Image Stock_Titan Posted - 04/24/24

$CARM Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting https://www.stocktitan.net/news/CARM/carisma-therapeutics-announces-upcoming-presentation-at-the-american-k4bvyp3aj0re.html

User Image Nicknar1213 Posted - 04/24/24

$CARM Averaged in at 1.88 Been daytrading this ticker for years with excellent results Really thought with 6 analytics as strong buys with a 6 to 10 range it was time to hold I was Wrong This ticker is still a Day Trading Wet Dream Missed out on thousands over past couple of weeks

User Image steven1x Posted - 04/23/24

$CARM https://wsw.com/webcast/chard18/register.aspx?conf=chard18&page=carm&url=https://wsw.com/webcast/chard18/carm/1902689

User Image Tim_SWFL Posted - 04/23/24

$CARM Howdy folks. Is there anyone in this thread who had/had Sensen Bio shares sitting in their Schwab account under a strange account classification? I have shares (stuck) that I am not sure what to do with? Any guidance would be greatly appreciated. Thx!

User Image SoccerPeter Posted - 04/23/24

$CARM ⬆️💰🚀 Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting 2024 Annual Meeting being held May 7-11, 2024, in Baltimore https://stkt.co/LGpdCFvb

User Image SoccerPeter Posted - 04/23/24

$CARM Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting 2024 Annual Meeting being held May 7-11, 2024, in Baltimore, MD. https://ir.carismatx.com/news-releases/news-release-details/carisma-therapeutics-present-new-data-american-society-gene-and

User Image ALdudei Posted - 04/22/24

$CARM anyone knows where Mike is? Remember ibrx? Obviously their drug got approved not our good ole viceneum.

User Image sorencyrus Posted - 04/22/24

$CARM nice runup today.

User Image Tim_SWFL Posted - 04/22/24

$CARM Does anyone know what is going to happen with our SESN shares? Sorry if this was already asked and answered. Thx in advance.

User Image steven1x Posted - 04/22/24

$CARM for cvr holders fyi https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-nogapendekin-alfa-inbakicept-pmln-bcg-unresponsive-non-muscle-invasive-bladder-cancer

User Image steven1x Posted - 04/22/24

$CARM https://www.prnewswire.com/news-releases/carisma-therapeutics-to-present-new-data-at-the-american-society-of-gene-and-cell-therapy-asgct-annual-meeting-302123620.html

User Image Stock_Titan Posted - 04/22/24

$CARM Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting https://www.stocktitan.net/news/CARM/carisma-therapeutics-to-present-new-data-at-the-american-society-of-desa1im4p6de.html

User Image Magnificient Posted - 04/22/24

$CARM Sesen Bio 4ever

User Image RallyRaider Posted - 04/22/24

$CARM wants to bottom sooo soo badly 4bln in biobucks by MRNA, THEY HAVE THE TECH

Analyst Ratings
BTIG Buy Apr 11, 24
HC Wainwright & Co. Buy Apr 2, 24
HC Wainwright & Co. Buy Nov 29, 23
Capital One Overweight Oct 3, 23
HC Wainwright & Co. Buy Sep 6, 23
HC Wainwright & Co. Buy Aug 11, 23
Evercore ISI Group Outperform Jul 6, 23
HC Wainwright & Co. Buy Jun 29, 23
Baird Outperform Jun 28, 23